![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Adaptive Design Saves Time, Money But Use in Late Stage Trials Still Risky
Adaptive Design Saves Time, Money But Use in Late Stage Trials Still Risky
August 22, 2011
Adaptive design can save R&D time and money by allowing clinical researchers to terminate a trial early if the desired outcome appears unlikely, a new report says.
Clinical Trials Advisor
Clinical Trials Advisor
Upcoming Events
-
21Oct